Gilead Sciences, Inc. (NASDAQ:GILD ) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants Jacquie Ross - Vice President, Investor Relations Daniel O'Day - Chairman and Chief

Gilead (GILD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

07:01pm, Thursday, 08'th Aug 2024

The headline numbers for Gilead (GILD) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates

Gilead Sciences (GILD) Q2 Earnings and Revenues Beat Estimates

06:15pm, Thursday, 08'th Aug 2024

Gilead Sciences (GILD) came out with quarterly earnings of $2.01 per share, beating the Zacks Consensus Estimate of $1.61 per share. This compares to earnings of $1.34 per share a year ago.

Gilead Eyes A Breakout After Second-Quarter Sales, Earnings Beat

04:20pm, Thursday, 08'th Aug 2024

Gilead stock is nearing a breakout after the company reported better-than-expected second-quarter sales and profit.

Gilead quarterly profit beats Street estimates, revenue up 5%

04:05pm, Thursday, 08'th Aug 2024

Gilead Sciences on Thursday reported second-quarter profit that handily beat Wall Street estimates, driven by lower operating expenses and higher product sales, and the drugmaker raised its outlook fo

Continuing Claims Hit Highest Since Nov 2021

11:30am, Thursday, 08'th Aug 2024

It's a big day for Wall Street as the much-awaited Jobless Claims numbers are out, which could be a major factor in market moves for the rest of the week. Right now, stock futures are climbing up as t

The Final Peak Week Of The Q2 Season Begins Amid Souring Economic Data

03:20am, Tuesday, 06'th Aug 2024

This marks the last peak week of the Q2 earnings season with 3,908 companies expected to report. Earnings have come in better-than-expected, but tend to be overshadowed by economic data. Outlier earni

Gilead's New Anti-Obesity Drug: The Real Reason Behind The 25% Stock Surge?

01:30pm, Monday, 05'th Aug 2024

After a disastrous performance in the first half of 2024, Gilead Sciences stock has rebounded strongly since mid-June. With Gilead Sciences due to report its Q2 results on Thursday, it's a good time t

Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?

12:41pm, Monday, 05'th Aug 2024

Let's look at five biotech and drug companies, AMGN, GILD, LLY, VTRS & NVO, due to release their second-quarter 2024 results this week.

Countdown to Gilead (GILD) Q2 Earnings: Wall Street Forecasts for Key Metrics

10:21am, Monday, 05'th Aug 2024

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Gilead (GILD), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the qua

2 Unstoppable Dividend Stocks to Buy if There's a Stock Market Sell-Off

06:45am, Saturday, 03'rd Aug 2024

Abbott Laboratories and Gilead Sciences are solid dividend stocks. Both look a bit pricey relative to their recent financial results.

Q3's Rising Stars: 3 Nasdaq Stocks for Your Must-Watch List

03:33pm, Friday, 02'nd Aug 2024

The growth and tech-heavy Nasdaq 100 index is in something of a significant correction at the moment. After hitting new all-time highs early in July, the benchmark Invesco QQQ ETF (NASDAQ: QQQ ) has a

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by